Variables | Values |
---|---|
Age (mean, SD, years) | 77.84 (6.82) |
Gender, female (%) | 71.20 |
Level of education (% > primary school) | 78.79 |
Age at diagnosis (mean, SD, years) | 76.77 (7.00) |
Cardiovascular risk factorsa (%) | 59.65 |
Cardiovascular disease (%) | 25.59 |
Painful osteoarthritis (%) | 8.50 |
Depression (%) | 37.17 |
Comorbidity (%) | |
0 | 28.09 |
1 | 37.96 |
≥ 2 | 33.95 |
MNA (% ≤ 23.5) | 33.03 |
Zarit score (mean, SD) | 22.63 (15.87) |
MMSE (mean, SD) | 20.02 (4.23) |
MMSE (%) | |
> 20 | 50.44 |
16 to 20 | 32.55 |
< 15 | 17.01 |
One leg balance test (% abnormal) | 15.06 |
ADL score (mean, SD) | 5.45 (0.87) |
Weight (kg, mean, SD) | 62.63 (12.76) |
BMI (%) | |
< 20 | 13.33 |
20 to 25 | 43.26 |
25 to 30 | 33.63 |
≥ 30 | 9.78 |
NPI (mean, SD) | 15.35 (15.30) |
NPI (%) | |
Delusions | 16.23 |
Hallucination | 6.73 |
Agitation/aggression | 36.99 |
Depression | 38.74 |
Anxiety | 42.25 |
Elation/euphoria | 7.02 |
Apathy | 53.51 |
Disinhibition | 10.96 |
Irritability/lability | 36.26 |
Aberrant motor behavior | 21.78 |
Sleep disorder | 14.62 |
Appetite disorder | 22.11 |
Treatment (%) | |
AChE inhibitors | 89.33 |
Psychotropic treatments | 50.15 |
Anti-Parkinsonian treatment | 1.32 |
Computed tomography scan (%) | |
Normal | 22.58 |
Atrophy alone | 26.69 |
Lacuna or stroke | 9.68 |
Hypodensity of the white matter | 12.17 |
Other | 8.65 |
CT scan not performed | 20.23 |